Brief: Anaptys To Receive $50 Mln In Capped Non-Recourse Monetization From Amended Agreement With Sagard In Exchange For Additional Jemperli Royalties
May 9 (Reuters) - AnaptysBio Inc ANAB.O :
* ANAPTYS TO RECEIVE $50 MILLION IN A CAPPED NON-RECOURSE
MONETIZATION FROM AMENDED AGREEMENT WITH SAGARD IN EXCHANGE FOR
ADDITIONAL JEMPERLI ROYALTIES
Source text for Eikon: ID:nGNXgmfQL
Further company coverage: ANAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged